PHOTRONICS INC (PLAB)

US7194051022 - Common Stock

24.04  -0.37 (-1.52%)

After market: 24.4 +0.36 (+1.5%)

Fundamental Rating

6

Overall PLAB gets a fundamental rating of 6 out of 10. We evaluated PLAB against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB gets an excellent profitability rating and is at the same time showing great financial health properties. PLAB is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, PLAB could be worth investigating further for value investing!.



7

1. Profitability

1.1 Basic Checks

PLAB had positive earnings in the past year.
In the past year PLAB had a positive cash flow from operations.
In the past 5 years PLAB has always been profitable.
In the past 5 years PLAB always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 7.63%, PLAB is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.66%, PLAB is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
PLAB has a better Return On Invested Capital (10.74%) than 80.56% of its industry peers.
PLAB had an Average Return On Invested Capital over the past 3 years of 12.91%. This is in line with the industry average of 11.24%.
Industry RankSector Rank
ROA 7.63%
ROE 11.66%
ROIC 10.75%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%

1.3 Margins

With a decent Profit Margin value of 15.07%, PLAB is doing good in the industry, outperforming 71.30% of the companies in the same industry.
In the last couple of years the Profit Margin of PLAB has grown nicely.
PLAB has a better Operating Margin (25.55%) than 85.19% of its industry peers.
In the last couple of years the Operating Margin of PLAB has grown nicely.
With a Gross Margin value of 36.44%, PLAB is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
PLAB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.55%
PM (TTM) 15.07%
GM 36.44%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PLAB is destroying value.
The number of shares outstanding for PLAB has been increased compared to 1 year ago.
The number of shares outstanding for PLAB has been reduced compared to 5 years ago.
The debt/assets ratio for PLAB has been reduced compared to a year ago.

2.2 Solvency

PLAB has a debt to FCF ratio of 0.14. This is a very positive value and a sign of high solvency as it would only need 0.14 years to pay back of all of its debts.
PLAB has a Debt to FCF ratio of 0.14. This is amongst the best in the industry. PLAB outperforms 86.11% of its industry peers.
PLAB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.00, PLAB is doing good in the industry, outperforming 69.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.14
Altman-Z N/A
ROIC/WACC0.69
WACC15.48%

2.3 Liquidity

PLAB has a Current Ratio of 5.07. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.07, PLAB is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
PLAB has a Quick Ratio of 4.76. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
PLAB's Quick ratio of 4.76 is amongst the best of the industry. PLAB outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 5.07
Quick Ratio 4.76

4

3. Growth

3.1 Past

PLAB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.94%.
The Earnings Per Share has been growing by 33.90% on average over the past years. This is a very strong growth
The Revenue has decreased by -2.82% in the past year.
Measured over the past years, PLAB shows a quite strong growth in Revenue. The Revenue has been growing by 9.50% on average per year.
EPS 1Y (TTM)-2.94%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-18.06%
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.13%

3.2 Future

The Earnings Per Share is expected to grow by 8.85% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.61% on average over the next years.
EPS Next Y8.18%
EPS Next 2Y8.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.11%
Revenue Next 2Y6.61%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

7

4. Valuation

4.1 Price/Earnings Ratio

PLAB is valuated correctly with a Price/Earnings ratio of 12.14.
Compared to the rest of the industry, the Price/Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 94.44% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.73. PLAB is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 11.22 indicates a reasonable valuation of PLAB.
Based on the Price/Forward Earnings ratio, PLAB is valued cheaper than 94.44% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PLAB to the average of the S&P500 Index (22.83), we can say PLAB is valued rather cheaply.
Industry RankSector Rank
PE 12.14
Fwd PE 11.22

4.2 Price Multiples

97.22% of the companies in the same industry are more expensive than PLAB, based on the Enterprise Value to EBITDA ratio.
96.30% of the companies in the same industry are more expensive than PLAB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.67
EV/EBITDA 2.82

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of PLAB may justify a higher PE ratio.
PEG (NY)1.48
PEG (5Y)0.36
EPS Next 2Y8.85%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PLAB!.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (12/20/2024, 8:00:00 PM)

After market: 24.4 +0.36 (+1.5%)

24.04

-0.37 (-1.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)12-11 2024-12-11/bmo
Earnings (Next)02-19 2025-02-19/amc
Inst Owners90.37%
Inst Owner Change-0.12%
Ins Owners3.84%
Ins Owner Change0.75%
Market Cap1.52B
Analysts82.86
Price Target32.64 (35.77%)
Short Float %3.74%
Short Ratio5.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.26%
Min EPS beat(2)-10.71%
Max EPS beat(2)11.24%
EPS beat(4)1
Avg EPS beat(4)-8.42%
Min EPS beat(4)-17.55%
Max EPS beat(4)11.24%
EPS beat(8)3
Avg EPS beat(8)-2.29%
EPS beat(12)6
Avg EPS beat(12)5.04%
EPS beat(16)9
Avg EPS beat(16)6.61%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.07%
Max Revenue beat(2)0.12%
Revenue beat(4)1
Avg Revenue beat(4)-4.86%
Min Revenue beat(4)-8.07%
Max Revenue beat(4)0.12%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)6
Avg Revenue beat(12)-0.68%
Revenue beat(16)7
Avg Revenue beat(16)-0.55%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)2.02%
EPS NQ rev (3m)2.02%
EPS NY rev (1m)-4.46%
EPS NY rev (3m)-4.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-2.66%
Revenue NY rev (3m)-2.66%
Valuation
Industry RankSector Rank
PE 12.14
Fwd PE 11.22
P/S 1.76
P/FCF 11.67
P/OCF 5.83
P/B 1.36
P/tB 1.36
EV/EBITDA 2.82
EPS(TTM)1.98
EY8.24%
EPS(NY)2.14
Fwd EY8.91%
FCF(TTM)2.06
FCFY8.57%
OCF(TTM)4.13
OCFY17.17%
SpS13.69
BVpS17.69
TBVpS17.69
PEG (NY)1.48
PEG (5Y)0.36
Profitability
Industry RankSector Rank
ROA 7.63%
ROE 11.66%
ROCE 14.49%
ROIC 10.75%
ROICexc 18.5%
ROICexgc 18.5%
OM 25.55%
PM (TTM) 15.07%
GM 36.44%
FCFM 15.05%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.14
Debt/EBITDA 0
Cap/Depr 158.17%
Cap/Sales 15.11%
Interest Coverage 250
Cash Conversion 85.91%
Profit Quality 99.83%
Current Ratio 5.07
Quick Ratio 4.76
Altman-Z N/A
F-Score5
WACC15.48%
ROIC/WACC0.69
Cap/Depr(3y)153.55%
Cap/Depr(5y)131.45%
Cap/Sales(3y)14.49%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.29%
Profit Quality(5y)132.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.94%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-18.06%
EPS Next Y8.18%
EPS Next 2Y8.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.13%
Revenue Next Year6.11%
Revenue Next 2Y6.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.47%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year50.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.6%
FCF growth 3Y46.5%
FCF growth 5YN/A
OCF growth 1Y-13.48%
OCF growth 3Y20.13%
OCF growth 5Y30.76%